BACKGROUND: Right ventricular (RV) failure after left ventricular assist device (LVAD) placement is a serious complication and is difficult to predict. In the era of destination therapy and the total artificial heart, predicting post-LVAD RV failure requiring mechanical support is extremely important. METHODS: We reviewed patient characteristics, laboratory values and hemodynamic data from 266 patients who underwent LVAD placement at the University of Pennsylvania from April 1995 to June 2007. RESULTS: Of 266 LVAD recipients, 99 required RV assist device (BiVAD) placement (37%). We compared 36 parameters between LVAD (n = 167) and BiVAD patients (n = 99) to determine pre-operative risk factors for RV assist device (RVAD) need. By univariate analysis, 23 variables showed statistically significant differences between the two groups (p < or = 0.05). By multivariate logistic regression, cardiac index < or =2.2 liters/min/m(2) (odds ratio [OR] 5.7), RV stroke work index < or =0.25 mm Hg . liter/m(2) (OR 5.1), severe pre-operative RV dysfunction (OR 5.0), pre-operative creatinine > or =1.9 mg/dl (OR 4.8), previous cardiac surgery (OR 4.5) and systolic blood pressure < or =96 mm Hg (OR 2.9) were the best predictors of RVAD need. CONCLUSIONS: The most significant predictors for RVAD need were cardiac index, RV stroke work index, severe pre-operative RV dysfunction, creatinine, previous cardiac surgery and systolic blood pressure. Using these data, we constructed an algorithm that can predict which LVAD patients will require RVAD with >80% sensitivity and specificity.
BACKGROUND:Right ventricular (RV) failure after left ventricular assist device (LVAD) placement is a serious complication and is difficult to predict. In the era of destination therapy and the total artificial heart, predicting post-LVAD RV failure requiring mechanical support is extremely important. METHODS: We reviewed patient characteristics, laboratory values and hemodynamic data from 266 patients who underwent LVAD placement at the University of Pennsylvania from April 1995 to June 2007. RESULTS: Of 266 LVAD recipients, 99 required RV assist device (BiVAD) placement (37%). We compared 36 parameters between LVAD (n = 167) and BiVADpatients (n = 99) to determine pre-operative risk factors for RV assist device (RVAD) need. By univariate analysis, 23 variables showed statistically significant differences between the two groups (p < or = 0.05). By multivariate logistic regression, cardiac index < or =2.2 liters/min/m(2) (odds ratio [OR] 5.7), RV stroke work index < or =0.25 mm Hg . liter/m(2) (OR 5.1), severe pre-operative RV dysfunction (OR 5.0), pre-operative creatinine > or =1.9 mg/dl (OR 4.8), previous cardiac surgery (OR 4.5) and systolic blood pressure < or =96 mm Hg (OR 2.9) were the best predictors of RVAD need. CONCLUSIONS: The most significant predictors for RVAD need were cardiac index, RV stroke work index, severe pre-operative RV dysfunction, creatinine, previous cardiac surgery and systolic blood pressure. Using these data, we constructed an algorithm that can predict which LVADpatients will require RVAD with >80% sensitivity and specificity.
Authors: Sharon A Hunt; David W Baker; Marshall H Chin; Michael P Cinquegrani; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Sidney Goldstein; Gabriel Gregoratos; Mariell L Jessup; R Joseph Noble; Milton Packer; Marc A Silver; Lynne Warner Stevenson; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith Journal: J Heart Lung Transplant Date: 2002-02 Impact factor: 10.247
Authors: David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Paul Aurora; Jason Christie; Fabienne Dobbels; Axel O Rahmel; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2007-08 Impact factor: 10.247
Authors: D J Farrar; J D Hill; D G Pennington; L R McBride; W L Holman; R L Kormos; D Esmore; L A Gray; P E Seifert; G P Schoettle; C H Moore; P J Hendry; J N Bhayana Journal: J Thorac Cardiovasc Surg Date: 1997-01 Impact factor: 5.209
Authors: Veli K Topkara; Nicholas C Dang; Fabio Barili; Faisal H Cheema; Timothy P Martens; Isaac George; Hasmet Bardakci; Mehmet C Oz; Yoshifumi Naka Journal: J Heart Lung Transplant Date: 2006-02-28 Impact factor: 10.247
Authors: M C Oz; D J Goldstein; P Pepino; A D Weinberg; S M Thompson; K A Catanese; R L Vargo; P M McCarthy; E A Rose; H R Levin Journal: Circulation Date: 1995-11-01 Impact factor: 29.690
Authors: R L Kormos; T A Gasior; A Kawai; S M Pham; S Murali; B G Hattler; B P Griffith Journal: J Thorac Cardiovasc Surg Date: 1996-04 Impact factor: 5.209
Authors: Yajuan Wang; Marc A Simon; Pramod Bonde; Bronwyn U Harris; Jeffrey J Teuteberg; Robert L Kormos; James F Antaki Journal: J Heart Lung Transplant Date: 2011-12-14 Impact factor: 10.247
Authors: O Wever-Pinzon; J Stehlik; A G Kfoury; J V Terrovitis; N A Diakos; C Charitos; D Y Li; S G Drakos Journal: Pharmacol Ther Date: 2012-01-16 Impact factor: 12.310
Authors: Pavan Atluri; Andrew B Goldstone; Alex S Fairman; John W MacArthur; Yasuhiro Shudo; Jeffrey E Cohen; Alexandra L Acker; William Hiesinger; Jessica L Howard; Michael A Acker; Y Joseph Woo Journal: Ann Thorac Surg Date: 2013-06-21 Impact factor: 4.330